CD4 and COVID-19: A T cell receptor (TCR)-dependent AIM assay was employed to determine SARS-CoV-2-specific CD4+ T cell responses in recovered COVID-19 patients immunized with COVID-19 vaccines, which has been successfully used to reveal vaccine-specific or virus-specific CD4+ T cells in several studies33,34.